Ellen M. Vromen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Microglia protein profiles in CSF across Alzheimer's disease clinical stages.
Journal: Nature aging
Published: June 02, 2025
Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.
Journal: Journal of Alzheimer's disease : JAD
Published: March 20, 2025
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways.
Journal: Molecular neurodegeneration
Published: November 26, 2024
Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project.
Journal: International journal of geriatric psychiatry
Published: March 06, 2024
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
Journal: Nature aging
Published: September 11, 2023
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Journal: Acta neuropathologica
Published: February 16, 2022
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical decline.
Journal: Brain communications
Published: September 24, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026